title: Argyria and decreased kidney function: are silver compounds toxic to the kidney?
authors.affiliation: Clinic for Transplantation Immunology and Nephrology, University Hospital, Basel, Switzerland. mmayr@uhbs.ch
authors.forename: Michael
authors.initials: M
authors.lastname: Mayr
authors.forename: Min Jeong
authors.initials: MJ
authors.lastname: Kim
authors.forename: Daniel
authors.initials: D
authors.lastname: Wanner
authors.forename: Hopfer
authors.initials: H
authors.lastname: Helmut
authors.forename: Josef
authors.initials: J
authors.lastname: Schroeder
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Mihatsch
mesh_terms: D001129:Argyria / Q000150:complications* / Q000473:pathology; D001706:Biopsy; D003937:Diagnosis, Differential; D005500:Follow-Up Studies; D005919:Glomerular Filtration Rate / Q000502:physiology*; D006801:Humans; D007668:Kidney / Q000503:physiopathology* / Q000648:ultrastructure; D007677:Kidney Function Tests; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D051437:Renal Insufficiency / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D018030:Silver Compounds / Q000009:adverse effects*; D012867:Skin / Q000473:pathology
chemical_list: D018030:Silver Compounds